caffeine has been researched along with Colicky Pain in 9 studies
Excerpt | Relevance | Reference |
---|---|---|
" Additional studies are needed to assess the relationship between caffeine dosing and clinical benefits in patients with TTH and migraine." | 6.55 | Caffeine in the management of patients with headache. ( Diener, HC; Garas, SY; Lipton, RB; Patel, K; Robbins, MS, 2017) |
" The global incidence of adverse events was 45% higher with EC, though not significant (32 vs." | 2.69 | Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks. ( Geraud, G; Gómez, JP; Henry, P; Joffroy, A; Lainez, JM; Le Jeunne, C; Liaño, H; Pradalier, A; Titus i Albareda, F, 1999) |
" Additional studies are needed to assess the relationship between caffeine dosing and clinical benefits in patients with TTH and migraine." | 2.55 | Caffeine in the management of patients with headache. ( Diener, HC; Garas, SY; Lipton, RB; Patel, K; Robbins, MS, 2017) |
"Effects of binge drinking on GI symptoms were strongest when comparing between individuals (rather than within individuals)." | 1.39 | Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome. ( Cain, KC; Eugenio, MD; Heitkemper, MM; Jarrett, ME; Reding, KW, 2013) |
" In this work, the antinociceptive and toxic effects of two new coordination complexes: Cu₂(fen)₄(caf)₂ [fen: fenoprofenate anion; caf: caffeine] and Cu₂(fen)₄(dmf)₂ [dmf: N-N'-dimethylformamide] were evaluated in mice." | 1.38 | Anti-nociceptive activity and toxicity evaluation of Cu(II)-fenoprofenate complexes in mice. ( Agotegaray, M; Bras, C; Gandini, NA; Gumilar, F; Minetti, A; Quinzani, O, 2012) |
"Prevalence of headache, stomachache, backache, and morning fatigue." | 1.32 | Headache, stomachache, backache, and morning fatigue among adolescent girls in the United States: associations with behavioral, sociodemographic, and environmental factors. ( Ghandour, RM; Huang, ZJ; Kogan, MD; Overpeck, MD; Scheidt, PC, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lipton, RB | 1 |
Diener, HC | 1 |
Robbins, MS | 1 |
Garas, SY | 1 |
Patel, K | 1 |
Wilson, PB | 1 |
Kromhout, HE | 1 |
Landstra, AM | 1 |
van Luin, M | 1 |
van Setten, PA | 1 |
de Wijkerslooth, LR | 1 |
Koch, BC | 1 |
Malingré, MM | 1 |
Smits, P | 1 |
Bartelink, AK | 1 |
Gumilar, F | 1 |
Agotegaray, M | 1 |
Bras, C | 1 |
Gandini, NA | 1 |
Minetti, A | 1 |
Quinzani, O | 1 |
Reding, KW | 1 |
Cain, KC | 1 |
Jarrett, ME | 1 |
Eugenio, MD | 1 |
Heitkemper, MM | 1 |
Ghandour, RM | 1 |
Overpeck, MD | 1 |
Huang, ZJ | 1 |
Kogan, MD | 1 |
Scheidt, PC | 1 |
Kueper, T | 1 |
Martinelli, D | 1 |
Konetzki, W | 1 |
Stamerjohn, RW | 1 |
Magill, JB | 1 |
Le Jeunne, C | 1 |
Gómez, JP | 1 |
Pradalier, A | 1 |
Titus i Albareda, F | 1 |
Joffroy, A | 1 |
Liaño, H | 1 |
Henry, P | 1 |
Lainez, JM | 1 |
Geraud, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Acute Headache Treatment in Pregnancy: Improvement in Pain Scores With Occipital Nerve Block vs PO Acetaminophen With Caffeine A Randomized Controlled Trial[NCT03951649] | Phase 4 | 62 participants (Actual) | Interventional | 2020-02-10 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT03951649)
Timeframe: 7 days
Intervention | days (Median) |
---|---|
Occipital Nerve Block | 6 |
Oral Acetaminophen/Caffeine Group | 1 |
(NCT03951649)
Timeframe: 28 days
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 9 |
Oral Acetaminophen/Caffeine Group | 4 |
(NCT03951649)
Timeframe: 7 days
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 7 |
Oral Acetaminophen/Caffeine Group | 2 |
Other: Pain at injection site (NCT03951649)
Timeframe: 7 days
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 0 |
Oral Acetaminophen/Caffeine Group | 2 |
(NCT03951649)
Timeframe: 7 hours
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 0 |
Oral Acetaminophen/Caffeine Group | 0 |
(NCT03951649)
Timeframe: 4 hours
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 9 |
Oral Acetaminophen/Caffeine Group | 14 |
(NCT03951649)
Timeframe: 5 hours
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 4 |
Oral Acetaminophen/Caffeine Group | 2 |
Emergency department for treatment of headache since treatment asked at 28 day follow up (NCT03951649)
Timeframe: 28 days
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 5 |
Oral Acetaminophen/Caffeine Group | 1 |
(NCT03951649)
Timeframe: 120 min
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 5 |
Oral Acetaminophen/Caffeine Group | 5 |
Based on guidelines from the International Headache Society the primary outcome is the portion of women who experience resolution of headache or improvement of headache to mild range (VRS ≤ 3) at 2 hours following treatment with Occipital nerve block as compared to acetaminophen/caffeine cocktail. (NCT03951649)
Timeframe: 60-300 min
Intervention | Participants (Count of Participants) |
---|---|
Occipital Nerve Block | 20 |
Oral Acetaminophen/Caffeine Group | 16 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 60 min
Intervention | score on a scale (Median) |
---|---|
Occipital Nerve Block | 6 |
Oral Acetaminophen/Caffeine Group | 3 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 180min
Intervention | score on a scale (Median) |
---|---|
Occipital Nerve Block | 6 |
Oral Acetaminophen/Caffeine Group | 4 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 2 hrs
Intervention | score on a scale (Median) |
---|---|
Occipital Nerve Block | 6.0 |
Oral Acetaminophen/Caffeine Group | 6.5 |
1 review available for caffeine and Colicky Pain
Article | Year |
---|---|
Caffeine in the management of patients with headache.
Topics: Abdominal Pain; Acetaminophen; Adult; Analgesics; Aspirin; Caffeine; Central Nervous System Stimulan | 2017 |
1 trial available for caffeine and Colicky Pain
Article | Year |
---|---|
Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Analgesics; Aspirin; Caffeine; Double-Blind Method; Drug Th | 1999 |
7 other studies available for caffeine and Colicky Pain
Article | Year |
---|---|
Dietary and non-dietary correlates of gastrointestinal distress during the cycle and run of a triathlon.
Topics: Abdominal Pain; Adult; Caffeine; Diet; Dietary Carbohydrates; Energy Intake; Female; Flatulence; Gas | 2016 |
[Acute caffeine intoxication after intake of 'herbal energy capsules'].
Topics: Abdominal Pain; Adolescent; Caffeine; Central Nervous System Stimulants; Dietary Supplements; Drug O | 2008 |
[Acute caffeine intoxication after intake of 'herbal energy capsules'].
Topics: Abdominal Pain; Caffeine; Central Nervous System Stimulants; Dietary Supplements; Female; Humans; Hy | 2008 |
Anti-nociceptive activity and toxicity evaluation of Cu(II)-fenoprofenate complexes in mice.
Topics: Abdominal Pain; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arousal; Caffeine; Cen | 2012 |
Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome.
Topics: Abdominal Pain; Adult; Alcohol Drinking; Binge Drinking; Caffeine; Case-Control Studies; Coffee; Con | 2013 |
Headache, stomachache, backache, and morning fatigue among adolescent girls in the United States: associations with behavioral, sociodemographic, and environmental factors.
Topics: Abdominal Pain; Adolescent; Adolescent Behavior; Alcohol Drinking; Back Pain; Caffeine; Comorbidity; | 2004 |
Identification of problem foods using food and symptom diaries.
Topics: Abdominal Pain; Adult; Caffeine; Child; Diet Records; Eating; Ethanol; Fatigue; Feeding Behavior; Fe | 1995 |